A pharmacovigilance data–driven approach to reveal high fatal adverse events following checkpoint immunotherapy

Journal:

Proceedings of the National Academy of Sciences of the United States of America

Published:

2026-03-02

DOI:

10.1073/pnas.2427234123

Affiliations:

9

Authors:

18

Go to article

Institutions	Authors	Share
State Key Laboratory of Systems Medicine for Cancer, SJTU, China	8.000000	0.44
Renji Hospital, SJTU, China	3.000000	0.17
Huashan Hospital, Fudan University, China	2.000000	0.11
The First Affiliated Hospital of Wenzhou Medical University, China	2.000000	0.11
Guangdong Academy of Medical Sciences (Guangdong Provincial People’s Hospital), China	1.000000	0.06
First Affiliated Hospital, USC, China	1.000000	0.06
City University of Hong Kong (CityU), China	1.000000	0.06

Interested in Oncology and Carcinogenesis?